OpenAI, in collaboration with Molecule.one, has demonstrated how a near-autonomous AI chemist powered by GPT-5.4 has successfully improved a crucial reaction in drug manufacturing. This advancement represents a significant step forward in medicinal chemistry research, showcasing the potential of AI technologies to enhance complex chemical processes.
Generative AINLPHealthcare+1
Generative AINLPHealthcareAI Chemist
Near-Autonomous AI Chemist Enhances Key Drug-Making Reaction in Medicinal Chemistry
OpenAI· OpenAI· Thursday, June 18, 2026
More Articles From This Day
AI RegulationLeadership+2
AI RegulationLeadershipAnthropicGenerative AI
US Order on Anthropic Models Marks New Chapter in AI Regulation
Dario Amodei, co-founder and CEO of Anthropic, discussed the company's innovative leadership approach during an interview on 'The Circuit with Emily Chang.' He emphasized the importance of focusing on big-picture discussions, organizational culture, and strategic input on research, rather than traditional management of senior leadership roles. This shift in leadership style comes as the US signals a new era for AI controls, with Anthropic at the forefront of these developments.